Journal metric profile

Current Reviews in Clinical and Experimental Pharmacology

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 0.900 2025 metric year
5-Year Impact Factor 1.000 Longer citation window
JCR Quartile Q4 Subject-category quartile
JCR Category Rank 312/352 Recorded category rank

Current Reviews in Clinical and Experimental Pharmacology JCR impact factor overview

Automatically generated from the journal record shown on this page.

Page reviewed August 6, 2026

Clarivate JCR impact factor overview

Current Reviews in Clinical and Experimental Pharmacology is listed in this directory with bibliometric information for 2025. It is published by BENTHAM SCIENCE PUBL LTD. The database records a Journal Impact Factor of 0.900, presented as a Clarivate Journal Citation Reports (JCR)-based metric. Its listed JCR Impact Factor quartile is Q4.

Ranking and quartile

The recorded JCR Impact Factor category rank is 312 out of 352 journals in its listed category. A Q4 designation describes the journal’s position within its subject category; it should not be used as a direct measure of the quality of an individual article.

Citation profile

The record contains 132 total citations, 8 total articles, 41 citable items. The five-year Impact Factor is 1.000, which is 0.100 points above the listed standard Journal Impact Factor. These values use different citation windows and should be interpreted together rather than as a direct trend. The Journal Impact Factor without journal self-citations is recorded as 0.900. The Journal Citation Indicator is listed as 0.310.

Citation half-life

The cited half-life is recorded as 2.2 years, describing the median age of articles cited in the reporting year. The citing half-life is 8.9 years, reflecting the median age of references used by the journal’s articles.

Journal identifiers and verification

Current Reviews in Clinical and Experimental Pharmacology is identified in this record by print ISSN 2772-4328 and electronic ISSN 2772-4336. Use the ISSN when checking library catalogues, publisher records, indexing databases, or the official Clarivate Journal Citation Reports entry.

Complete journal information

All values below come directly from the database record.

Journal nameCurrent Reviews in Clinical and Experimental Pharmacology
Abbreviated journalCURR REV CLIN EXP PH
PublisherBENTHAM SCIENCE PUBL LTD
Metric year2025
Overall rank14,036
ISSN2772-4328
eISSN2772-4336
Total cites132
Total articles8
Citable items41
Cited half-life2.2 years
Citing half-life8.9 years
JCR-based Journal Impact Factor0.900
5-Year Impact Factor1.000
Impact Factor without journal self-cites0.900
Journal Citation Indicator0.310
JCR Impact Factor quartileQ4
JCR category rank312/352
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of Current Reviews in Clinical and Experimental Pharmacology?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for Current Reviews in Clinical and Experimental Pharmacology is 0.900 for the 2025 metric year.

What quartile is Current Reviews in Clinical and Experimental Pharmacology?

Current Reviews in Clinical and Experimental Pharmacology is listed in quartile Q4. Quartiles describe a journal’s position within a subject category and should be interpreted within that field.

Who publishes Current Reviews in Clinical and Experimental Pharmacology?

Current Reviews in Clinical and Experimental Pharmacology is listed as being published by BENTHAM SCIENCE PUBL LTD.

Can a JCR Journal Impact Factor be used to judge an individual article?

No. The Journal Impact Factor is a journal-level citation measure reported in Clarivate Journal Citation Reports. It does not measure the quality, reliability or influence of every individual article published by that journal.

Additional records from the same publisher or with a similar listed JCR Impact Factor.